Literature DB >> 32578174

The Immune Consequences of Lactate in the Tumor Microenvironment.

Cathal Harmon1,2, Cliona O'Farrelly2,3, Mark W Robinson4.   

Abstract

The tumor microenvironment consists of complex and dynamic networks of cytokines, growth factors, and metabolic products. These contribute to significant alterations in tissue architecture, cell growth, immune cell phenotype, and function. Increased glycolytic flux is commonly observed in solid tumors and is associated with significant changes in metabolites, generating high levels of lactate. While elevated glycolytic flux is a characteristic metabolic adaption of tumor cells, glycolysis is also a key metabolic program utilized by a variety of inflammatory immune cells. As such lactate and the pH changes associated with lactate transport affect not only tumor cells but also immune cells. Here we provide an overview of lactate metabolic pathways and the effects lactate has on tumor growth and immune cell function. This knowledge provides opportunities for synergistic therapeutic approaches that combine metabolic drugs, which limit tumor growth and support immune cell function, together with immunotherapies to enhance tumor eradication.

Entities:  

Keywords:  Anti-tumor immunity; Biosynthesis; Glycolysis; Immunotherapy; Lactate; Lactic acid; MCT; Macrophages; Metabolic therapies; Metabolism; NK cells; T cells; Tumor microenvironment; Warburg; pH

Mesh:

Substances:

Year:  2020        PMID: 32578174     DOI: 10.1007/978-3-030-43093-1_7

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  9 in total

1.  Quantitative Longitudinal Imaging Reveals that Inhibiting Hedgehog Activity Alleviates the Hypoxic Tumor Landscape.

Authors:  Tshering D Lama-Sherpa; Shamik Das; Dominique C Hinshaw; Sarah C Kammerud; Patrick N Song; Heba A Alsheikh; Anna G Sorace; Rajeev S Samant; Lalita A Shevde
Journal:  Mol Cancer Res       Date:  2021-09-30       Impact factor: 6.333

2.  Solute carrier family 2 members 1 and 2 as prognostic biomarkers in hepatocellular carcinoma associated with immune infiltration.

Authors:  Qing Peng; Li-Yuan Hao; Ying-Lin Guo; Zhi-Qin Zhang; Jing-Min Ji; Yu Xue; Yi-Wei Liu; Jun-Lan Lu; Cai-Ge Li; Xin-Li Shi
Journal:  World J Clin Cases       Date:  2022-05-06       Impact factor: 1.534

3.  Blocking circ-CNST suppresses malignant behaviors of osteosarcoma cells and inhibits glycolysis through circ-CNST-miR-578-LDHA/PDK1 ceRNA networks.

Authors:  Rui Hu; Shan Chen; Jianxin Yan
Journal:  J Orthop Surg Res       Date:  2021-05-07       Impact factor: 2.359

Review 4.  The cancer metabolic reprogramming and immune response.

Authors:  Longzheng Xia; Linda Oyang; Jinguan Lin; Shiming Tan; Yaqian Han; Nayiyuan Wu; Pin Yi; Lu Tang; Qing Pan; Shan Rao; Jiaxin Liang; Yanyan Tang; Min Su; Xia Luo; Yiqing Yang; Yingrui Shi; Hui Wang; Yujuan Zhou; Qianjin Liao
Journal:  Mol Cancer       Date:  2021-02-05       Impact factor: 27.401

5.  A TP53-Associated Immune Prognostic Signature for the Prediction of Overall Survival and Therapeutic Responses in Muscle-Invasive Bladder Cancer.

Authors:  Xiangkun Wu; Daojun Lv; Chao Cai; Zhijian Zhao; Ming Wang; Wenzhe Chen; Yongda Liu
Journal:  Front Immunol       Date:  2020-12-17       Impact factor: 7.561

6.  Overexpression of Pyruvate Dehydrogenase Kinase-3 Predicts Poor Prognosis in Urothelial Carcinoma.

Authors:  Yu-Hsuan Kuo; Ti-Chun Chan; Hong-Yue Lai; Tzu-Ju Chen; Li-Ching Wu; Chung-Hsi Hsing; Chien-Feng Li
Journal:  Front Oncol       Date:  2021-09-13       Impact factor: 6.244

7.  Predictive value of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio in evaluating both lung involvement and severity of patients with coronavirus disease 2019.

Authors:  Yusuf Aksu; Ali U Uslu; Gülten Tarhan; Mustafa Karagülle
Journal:  Saudi Med J       Date:  2021-11       Impact factor: 1.422

Review 8.  Targeted Arginine Metabolism Therapy: A Dilemma in Glioma Treatment.

Authors:  Xiaoshuang Hou; Sui Chen; Po Zhang; Dongsheng Guo; Baofeng Wang
Journal:  Front Oncol       Date:  2022-07-11       Impact factor: 5.738

9.  Glycolysis Changes the Microenvironment and Therapeutic Response Under the Driver of Gene Mutation in Esophageal Adenocarcinoma.

Authors:  Lei Zhu; Fugui Yang; Xinrui Li; Qinchuan Li; Chunlong Zhong
Journal:  Front Genet       Date:  2021-12-08       Impact factor: 4.599

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.